Dolutegravir 25 mg and 50 mg and Oxybutynin Extended-Release Tablets
Determining the interaction of Dolutegravir 25 mg and 50 mg and Oxybutynin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir 25 mg and 50 mg-Oxybutynin Gel
- Dolutegravir 25 mg and 50 mg-Oxybutynin Oral Solution
- Dolutegravir 25 mg and 50 mg-Oxybutynin Syrup
- Dolutegravir 25 mg and 50 mg-Oxybutynin Tablets
- Dolutegravir 25 mg and 50 mg-Oxybutynin transdermal
- Dolutegravir 25 mg and 50 mg-Oxybutynin Transdermal System
- Oxybutynin Extended-Release Tablets-Dolutegravir and lamivudine
- Oxybutynin Extended-Release Tablets-Dolutegravir and rilpivirine
- Oxybutynin Extended-Release Tablets-Dolutegravir Sodium
- Oxybutynin Extended-Release Tablets-Dolutegravir Sodium And Lamivudine
- Oxybutynin Extended-Release Tablets-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Oxybutynin Extended-Release Tablets-Dom-Etoposide